Cellular location and expression of Na+, K+-ATPase α subunits affect the anti-proliferative activity of oleandrin

Molecular Carcinogenesis

Volumn 53, Issue 4, 2014, Pages 253-263

  Yang, Peiying ^a   Cartwright, Carrie ^a   Efuet, Ekem ^a   Hamilton, Stanley R ^a   Wistuba, Ignacio Ivan ^a   Menter, David ^a   Addington, Crandell ^b   Shureiqi, Imad ^a   Newman, Robert A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Phoenix Biotechnology Inc   (United States)

Author keywords

CaCO 2 cells; Cardiac glycoside; Colon tissues; Na, K ATPase 3 isoform; Oleandrin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA SUBUNIT; ANTINEOPLASTIC AGENT; MEMBRANE PROTEIN; OLEANDRIN; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR LOCALIZATION;

CACO-2 CELLS; CARDIAC GLYCOSIDE; COLON TISSUES; NA, K-ATPASE Α3 ISOFORM; OLEANDRIN;

CACO-2 CELLS; CARDENOLIDES; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON; HT29 CELLS; HUMANS; LUNG; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84895823295     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21968     Document Type: Article

References (43)

1. Kjeldsen K, Norgaard A, Gheorghiade M. Myocardial Na, K-ATPase: The molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure. Cardiovasc Res 2002; 55:710-713.
2. Haux J. Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses 1999; 53:543-548.
3. Stenkvist B. Is digitalis a therapy for breast carcinoma? Oncol Rep 1999; 6:493-496.
4. Yeh JY, Huang WJ, Kan SF, Wang PS. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. J Urol 2001; 166:1937-1942.
5. 2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 2000; 60:3807-3812.
6. Turan N, Akgun-Dar K, Kuruca SE, et al. Cytotoxic effects of leaf, stem and root extracts of Nerium oleander on leukemia cell lines and role of the p-glycoprotein in this effect. J Exp Ther Oncol 2006; 6:31-38.
7. Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res 2006; 66:5867-5874.
8. Pathak S, Multani AS, Narayan S, Kumar V, Newman RA. Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs 2000; 11:455-463.
9. Raghavendra PB, Sreenivasan Y, Ramesh GT, Manna SK. Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases. Apoptosis 2007; 12:307-318.
10. Sreenivasan Y, Raghavendra PB, Manna SK. Oleandrin-mediated expression of Fas potentiates apoptosis in tumor cells. J Clin Immunol 2006; 26:308-322.
11. Newman RA, Kondo Y, Yokoyama T, et al. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Integr Cancer Ther 2007; 6:354-364.
12. Srivastava M, Eidelman O, Zhang J, et al. Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci USA 2004; 101:7693-7698.
13. Yang Q, Huang W, Jozwik C, et al. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci USA 2005; 102:9631-9636.
14. Rose AM, Valdes R, Jr. Understanding the sodium pump and its relevance to disease. Clin Chem 1994; 40:1674-1685.
15. Lin Y, Dubinsky WP, Ho DH, Felix E, Newman RA. Determinants of human and mouse melanoma cell sensitivities to oleandrin. J Exp Ther Oncol 2008; 7:195-205.
16. Smith JA, Madden T, Vijjeswarapu M, Newman RA. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol 2001; 62:469-472.
17. Yang P, Menter DG, Cartwright C, et al. Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na, -ATPase alpha subunits as drug targets. Mol Cancer Ther 2009; 8:2319-2328.
18. Kaplan JH. A moving new role for the sodium pump in epithelial cells and carcinomas. Sci STKE 2005; 2005:pe31-pe40.
19. +-ATPase-mediated signal transduction: From protein interaction to cellular function. Mol Interv 2003; 3:157-168.
20. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007; 1776:32-57.
21. Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 2008; 8:36-49.
22. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: Heterogeneity in structure, diversity in function. Am J Physiol 1998; 275:F633-F650.
23. Rajasekaran SA, Ball WJ, Jr., Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of beta-subunit of Na, K-ATPase in human clear-cell renal cell carcinoma. J Urol 1999; 162:574-580.
24. Avila J, Lecuona E, Morales M, Soriano A, Alonso T, Martin-Vasallo P. Opposite expression pattern of the human Na, K-ATPase beta 1 isoform in stomach and colon adenocarcinomas. Ann N Y Acad Sci 1997; 834:653-655.
25. Espineda C, Seligson DB, James Ball W, Jr., et al. Analysis of the Na, K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 2003; 97:1859-1868.
26. Jung MH, Kim SC, Jeon GA, et al. Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics 2000; 69:281-286.
27. Blanco G. Na, K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol 2005; 25:292-303.
28. Rajasekaran SA, Barwe SP, Rajasekaran AK. Multiple functions of Na, -ATPase in epithelial cells. Semin Nephrol 2005; 25:328-334.
29. Dunbar LA, Caplan MJ. Ion pumps in polarized cells: Sorting and regulation of the Na+, K+- and H+, K+-ATPases. J Biol Chem 2001; 276:29617-29620.
30. Podevin RA, Parini A. Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes. J Pharmacol Exp Ther 1989; 250:672-677.
31. Saumon G, Basset G, Bouchonnet F, Crone C. Cellular effects of beta-adrenergic and of cAMP stimulation on potassium transport in rat alveolar epithelium. Pflugers Arch 1989; 414:340-345.
32. Benfante R, Antonini RA, Vaccari M, et al. The expression of the human neuronal alpha3 Na+, K+-ATPase subunit gene is regulated by the activity of the Sp1 and NF-Y transcription factors. Biochem J 2005; 386:63-72.
33. Yang P, Chan D, Felix E, et al. Formation and antiproliferative effect of Prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 2004; 45:1030-1039.
34. Shureiqi I, Wojno KJ, Poore JA, et al. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 1999; 20:1985-1995.
35. Raso MG, Behrens C, Herynk MH, et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 2009; 15:5359-5368.
36. Moussalli MJ, Wu Y, Zuo X, et al. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Cancer Prev Res 2011; 4:1961-1972.
37. Mobasheri A, Avila J, Cozar-Castellano I, et al. Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 2000; 20:51-91.
38. Raghavendra PB, Sreenivasan Y, Manna SK. Oleandrin induces apoptosis in human, but not in murine cells: Dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity. Mol Immunol 2007; 44:2292-2302.
39. Matsumoto H, Erickson RH, Gum JR, Yoshioka M, Gum E, Kim YS. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 1990; 98:1199-1207.
40. Sweadner KJ. Enzymatic properties of separated isozymes of the Na, K-ATPase. Substrate affinities, kinetic cooperativity, and ion transport stoichiometry. J Biol Chem 1985; 260:11508-11513.
41. + pump alpha subunit isoforms in plasmalemma. Physiological implications. Ann N Y Acad Sci 1997; 834:524-536.
42. Mijatovic T, Roland I, Van Quaquebeke E, et al. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol 2007; 212:170-179.
43. Rajasekaran SA, Huynh TP, Wolle DG, et al. Na, K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther 2010; 9:1515-1524.